New international charter responds to growing concern at heart of digital healthcare: who owns the data produced by smart medical devices.

A new international Diabetes Data Rights Charter is calling for people with diabetes to have far greater control over the health data generated by 24/7 diabetes monitoring devices.
Developed through an 18-month international collaboration involving those living with diabetes, clinicians, researchers and patient advocates, the Charter responds to a growing concern at the heart of digital healthcare: who owns the data produced by smart medical devices?
Continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems generate vast amounts of highly personal health data. People with diabetes have limited access to their data or control over how that data is collected, shared and used.
Project co-leader Muireann Quigley, Professor of Law, Medicine, and Technology at the University of Birmingham, said: “Across the world, people with diabetes have had their quality of life improved by smart medical devices, such as continuous glucose monitors and automated insulin pumps, to help them manage their diabetes. However, as with most kinds of modern technology, questions around access to and control of the data gathered by these devices and their manufacturers remain fraught.
“Users of these devices often don’t have full access to their own data, or don’t know how it is being used by the medical device companies. This Charter aims to establish a new benchmark for best practice across the diabetes technology sector, allowing people with diabetes to have better transparency and control when it comes to their data.”
The Charter is built around five core principles with accompanying rights:
- Data Access: People with diabetes should be able to access real-time data, safely and securely, when and where they choose, in a format they can use.
- Privacy and Security: Diabetes data should be stored and transferred privately and securely.
- Benefits and Interests: Diabetes data reflects the lives and health of people. Regardless of how data are collected, formatted, or used – the needs and interests of those most affected must come first.
- Choice and Control: People with diabetes should be able to meaningfully consent to what data are shared, with whom, and for what purposes.
- Accountability and Transparency: Stakeholders should be transparent about, and accountable for, how diabetes data are collected, stored, and used.
The Charter also raises concerns about what it describes as ‘bundled’ or ‘coerced’ consent. This is where users must agree to extensive data-sharing arrangements to access key device functions. Lengthy device terms and conditions can also limit understanding of how data will be used. The authors of the Charter are calling for greater transparency around how data is used to develop products and algorithms.
Dexcom – one of the world’s leading CGM manufacturers – faced lawsuits and public outcry from the global diabetes community when it pushed an in-app notification requiring users to accept a number of updated terms or discontinue use of the app. Such practices can be common among connected devices, where access to core functionality depends on agreeing to privacy policies that allow continuous data sharing with manufacturers. If users withdraw consent, critical features may stop working, leaving them with no meaningful alternative.
Dr. Shane O’Donnell is a Research Fellow at University College Dublin and co-lead on the Charter project, and lives with diabetes. He added: “What episodes like Dexcom reveal is that people care intimately about the data they rely on to make life-or-death decisions every single day. The Diabetes Data Rights Charter helps the community articulate those concerns – and challenges the wider healthcare system to adopt data practices that more adequately meet their needs.”
Tim Street, who lives with type 1 diabetes and covers diabetes technology extensively on his blog, Diabettech, said: “Until about 10 years ago, my records were mine: pen, paper, and whatever I chose to write down. CGMs and apps have dramatically improved my life with type 1 diabetes, but I’ve lost the ability to look back at the granular data. Access to my data in the format I want, not only how a manufacturer decides I should get it, is one of the many reasons why this Charter is important to me. I have rights over the health data generated by my body.”
The fundamental principles outlined in the Charter are compatible with existing data governance frameworks, including the EU and UK General Data Protection Regulation and US Health Insurance Portability and Accountability Act. However, the Charter goes beyond existing legal rights to articulate standards of best practice for those interacting with and entrusted with the care of this data.

